to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.
Immunoglobulin Fc Fragments
Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic.
A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
Defining the Binding Region in Factor H to Develop a Therapeutic Factor H-Fc Fusion Protein against Non-Typeable Haemophilus influenzae.
Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.
Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against Neisseria gonorrhoeae.
Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine.
Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae.
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae.